Medicine
Repaglinide 0.5 mg tablet
Repaglinide 0.5 mg tablet is a generic prescription medicine for oral use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20º to 25º C (68º to 77º F), excursions permitted to 15º to 30ºC (59º…
Key facts
- Active ingredient (INN)
- Repaglinide
- Brand
- Sold under the generic name
- Strength
- 0.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 1000 tablets and 10 more
- Manufacturers
- Aurobindo PharmaIndiaMacleods PharmaceuticalsIndiaBryant Ranch PrepackRising Pharma HoldingsChartwell RXNorthStar RxLLC
- Origin register
- US FDA, United States
- Storage
- Store at 20º to 25º C (68º to 77º F), excursions permitted to 15º to 30ºC (59º to 86º F). Protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BX02 Repaglinide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 November 2013
- Identifiers
- RxCUI 200256, 200257, 200258DailyMed set ID 7f3118ce-fcbb-4f8b-b1ba-d8cd95e5b665, 68064989-47ea-4ed5-a20e-43c4ef6ec271, 3b150917-e2fd-4366-af83-ebc1d7297ca9 +4NDC 72603-810, 65862-670, 63629-4866 +4Application ANDA207209, ANDA203820, ANDA078555
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 65862-670-01 | Aurobindo PharmaIndia | 22 January 2014 |
| 500 tablet in 1 bottle | 65862-670-05 | Aurobindo PharmaIndia | 22 January 2014 |
| 1000 tablet in 1 bottle | 65862-670-99 | Aurobindo PharmaIndia | 22 January 2014 |
| 100 tablet in 1 bottle | 33342-248-11 | Macleods PharmaceuticalsIndia | 22 March 2023 |
| 1000 tablet in 1 bottle | 33342-248-44 | Macleods PharmaceuticalsIndia | 22 March 2023 |
| 90 tablet in 1 bottle | 62135-946-90 | Chartwell RX | 24 April 2025 |
| 100 tablet in 1 bottle | 57237-157-01 | Rising Pharma Holdings | 22 January 2014 |
| 500 tablet in 1 bottle | 57237-157-05 | Rising Pharma Holdings | 22 January 2014 |
| 30 tablet in 1 bottle | 63629-4866-1 | Bryant Ranch Prepack | 16 January 2025 |
| 90 tablet in 1 bottle | 63629-4866-2 | Bryant Ranch Prepack | 16 January 2025 |
| 30 tablet in 1 bottle | 71335-2554-1 | Bryant Ranch Prepack | 23 January 2025 |
| 90 tablet in 1 bottle | 71335-2554-2 | Bryant Ranch Prepack | 23 January 2025 |
| 100 tablet in 1 bottle | 72603-810-01 | NorthStar RxLLC | 8 April 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Repaglinide
Clinical summary
Repaglinide is a glinide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available as tablets for oral use. MedsAcross supplies Repaglinide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RepaglinideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Repaglinide prescribing information (NorthStar RxLLC) · U.S. National Library of Medicine, DailyMed
- NovoNorm: European public assessment report (EPAR) · European Medicines Agency
- Prandin: European public assessment report (EPAR) · European Medicines Agency
Need Repaglinide 0.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.